乙胺丁醇
医学
视神经炎
强的松
肺结核
外科
眼科
异烟肼
多发性硬化
病理
免疫学
作者
Jaykumar Patel,Chetna Patel,Akash Shah,P.G. Shah,S. Pandya,Brijesh Sojitra
出处
期刊:Cureus
[Cureus, Inc.]
日期:2024-07-18
摘要
Ethambutol is a first-line chemotherapeutic agent, which is commonly used in combination with other drugs for the treatment of tuberculosis. Ethambutol-induced optic neuritis is a serious and rare side effect that is either dose or duration-related and causes progressive painless vision loss, and cecocentral scotomas in the visual field. A rare case of ethambutol-induced optic neuritis was reported in a 52-year-old female who was taking anti-tubercular treatment for pulmonary tuberculosis for five months. She presented with painless diminished vision in both eyes. The patient was diagnosed with a rare case of optic neuritis through various examination methods. Ethambutol was stopped and therapy was continued with oral prednisone, zinc, and vitamin B complex being started along with anti-TB treatment. She showed no marked improvement in visual parameters until the last follow-up. The patient died due to cardiopulmonary arrest as a consequence of pulmonary tuberculosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI